BruceRBaconMD

PubMed

• 2 citations
  Accelerating Care Through ECHO: Case Examples from the Field.
  Mirna Becevic, Emmanuelle Wallach, Lincoln Sheets, Hope Misterovich, Susan Norris, Evelyn Aboagye, Jonathan A. Dyer, Bruce R. Bacon, Karen E. Edison, Kristin Sohl> ;Missouri Medicine. 2020 May 1
• 19 citations
  Effectiveness of 8-Week Glecaprevir/Pibrentasvir for Treatment-Naïve, Compensated Cirrhotic Patients with Chronic Hepatitis C Infection.
  Jens Kort, Steven E Marx, John Strezewski, Douglas E. Dylla, Bruce R. Bacon, Michael P. Curry, Naoky Tsai, Nicole Wick> ;Advances in Therapy. 2020 Apr 11
• Sporadic Porphyria Cutanea Tarda as the Initial Manifestation of Hereditary Hemochromatosis.
  Mitchell Edwards, Jennifer Michelle Ray, Bruce R Bacon> ;ACG Case Reports Journal. 2019 Nov 1
• 4 citations
  Changing demographics among populations prescribed HCV treatment, 2013-2017.
  Naoky Tsai, Bruce R. Bacon, Michael P. Curry, Scott Milligan, Nicole Wick, Zobair M. Younossi, Nezam H. Afdhal> ;The American Journal of Managed Care. 2019 Jul 1
• 45 citations
  A Randomized, Controlled, Phase 2 Study of Maralixibat in the Treatment of Itching Associated With Primary Biliary Cholangitis.
  Marlyn J. Mayo, Paul J. Pockros, David Jones, Christopher L. Bowlus, Cynthia Levy, I Patanwala, Bruce R. Bacon, Velimir A. Luketic, Raj Vuppalanchi, Sharon Medendorp, ...> ;Hepatology Communications. 2019 Mar 1
• 15 citations
  Efficacy and Pharmacokinetics of Glecaprevir and Pibrentasvir With Concurrent Use of Acid-Reducing Agents in Patients With Chronic HCV Infection
  K. Rajender Reddy, Neddie Zadeikis, Tarek Hassanein, Bruce R. Bacon, Andreas Maieron, Stefan Zeuzem, Marc Bourlière, Jose Luis Calleja, Matthew P. Kosloski, Rajneet K....> ;Clinical Gastroenterology and Hepatology. 2019 Feb 1
• 26 citations
  Real-world use of elbasvir-grazoprevir in patients with chronic hepatitis C: retrospective analyses from the TRIO network.
  Bruce R. Bacon, Michael P. Curry, Scott Milligan, C. Nwankwo, Naoky Tsai, Zobair M. Younossi, Nezam H. Afdhal> ;Alimentary Pharmacology & Therapeutics. 2018 Jun 1
• 14 citations
  New scoring classification for primary biliary cholangitis-autoimmune hepatitis overlap syndrome.
  Wei Zhang, Debapriya De, Kahee A. Mohammed, Satish Munigala, Guilan Chen, Jin-Ping Lai, Bruce R. Bacon> ;Hepatology Communications. 2018 Feb 20
• 51 citations
  Positive Iron Balance in Chronic Kidney Disease: How Much is Too Much and How to Tell?
  Jay B. Wish, George R. Aronoff, Bruce R. Bacon, Carlo Brugnara, Kai-Uwe Eckardt, Tomas Ganz, Iain C. Macdougall, Julio Núñez, Adam J Perahia, John C. Wood> ;American Journal of Nephrology. 2018 Jan 1
• 102 citations
  Seladelpar (MBX-8025), a selective PPAR-δ agonist, in patients with primary biliary cholangitis with an inadequate response to ursodeoxycholic acid: a double-blind, ra...
  , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , > ;The Lancet. Gastroenterology & Hepatology. 2017 Oct 1
• 30 citations
  Effectiveness of 8‐ or 12‐weeks of ledipasvir and sofosbuvir in real‐world treatment‐naïve, genotype 1 hepatitis C infected patients
  Michael P. Curry, Elliot B. Tapper, Bruce R. Bacon, Douglas T. Dieterich, Lauren Guest, Kris V. Kowdley, Y. Lee, Scott Milligan, Naoky Tsai, Zobair M. Younossi, Nezam ...> ;Alimentary Pharmacology & Therapeutics. 2017 Jul 10
• 7 citations
  Hepatitis C Virus Infection Care Pathway—A Report From the American Gastroenterological Association Institute HCV Care Pathway Work Group
  Fasiha Kanwal, Bruce R. Bacon, Lauren A. Beste, Joel V. Brill, Allen L. Gifford, Stuart C. Gordon, Michael A. Horberg, Jacob Manthey, Nancy Reau, Vinod K. Rustgi, Zoba...> ;Gastroenterology. 2017 May 1
• 41 citations
  Activation of Insulin-PI3K/Akt-p70S6K Pathway in Hepatic Stellate Cells Contributes to Fibrosis in Nonalcoholic Steatohepatitis
  Cindy X. Cai, Hema Buddha, Shobha Castelino-Prabhu, Zhiwei Zhang, Robert S. Britton, Bruce R. Bacon, Brent A. Neuschwander-Tetri> ;Digestive Diseases and Sciences. 2017 Feb 13
• 61 citations
  Real-world effectiveness for 12 weeks of ledipasvir–sofosbuvir for genotype 1 hepatitis C: the Trio Health study
  Elliot B. Tapper, Bruce R. Bacon, Michael P. Curry, Douglas T. Dieterich, Lauren Guest, Kris V. Kowdley, Y. Lee, Naoky Tsai, Zobair M. Younossi, Nezam H. Afdhal> ;Journal of Viral Hepatitis. 2017 Jan 1
• 51 citations
  Evaluation of proton pump inhibitor use on treatment outcomes with ledipasvir and sofosbuvir in a real-world cohort study.
  Elliot B. Tapper, Bruce R. Bacon, Michael P. Curry, Douglas T. Dieterich, Lauren Guest, Kris V. Kowdley, Y. Lee, Naoky Tsai, Zobair M. Younossi, Nezam H. Afdhal> ;Hepatology. 2016 Dec 1
• 45 citations
  Disparate access to treatment regimens in chronic hepatitis C patients: Data from the TRIO network
  Zobair M. Younossi, Bruce R. Bacon, Douglas T. Dieterich, Kris V. Kowdley, Scott Milligan, Naoky Tsai, A. Nezam> ;Journal of Viral Hepatitis. 2016 Jun 1
• 188 citations
  International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways
  Heather J. Cordell, Younghun Han, George F. Mells, Yafang Li, Gideon M. Hirschfield, Casey S. Greene, Gang Xie, Brian D. Juran, Dakai Zhu, David C. Qian, James A B Flo...> ;Nature Communications. 2015 Sep 22
• 139 citations
  Accuracy of Fibroscan, Compared With Histology, in Analysis of Liver Fibrosis in Patients With Hepatitis B or C: A United States Multicenter Study
  Nezam H. Afdhal, Bruce R. Bacon, Keyur Patel, Eric Lawitz, Stuart C Gordon, David R. Nelson, Tracy Challies, Imad Nasser, Jyotsna Garg, Lee-Jen Wei, John G. McHutchison> ;Clinical Gastroenterology and Hepatology. 2015 Apr 1
• 1 citations
  Measurement of Hepatic Iron Concentration
  Bruce R. Bacon> ;Clinical Gastroenterology and Hepatology. 2015 Jan 1
• 21 citations
  Safety and efficacy of boceprevir/peginterferon/ribavirin for HCV G1 compensated cirrhotics: meta-analysis of 5 trials.
  , , , , , , , , , , , , , , , > ;Journal of Hepatology. 2014 Aug 1
• 29 citations
  The Combination of MK-5172, Peginterferon, and Ribavirin Is Effective in Treatment-Naive Patients With Hepatitis C Virus Genotype 1 Infection Without Cirrhosis
  Michael P. Manns, John M. Vierling, Bruce R. Bacon, Savino Bruno, Oren Shibolet, Yaacov Baruch, Patrick Marcellin, Luzelena Caro, Anita Y. M. Howe, Christine Fandozzi,...> ;Gastroenterology. 2014 Aug 1
• 34 citations
  The Quality of Care Provided to Patients With Varices in the Department of Veterans Affairs
  Paula Buchanan, Jennifer R. Kramer, Hashem B. El-Serag, Steven M. Asch, Youssef Assioun, Bruce R. Bacon, Fasiha Kanwal> ;The American Journal of Gastroenterology. 2014 Jul 1
• 14 citations
  Overall safety profile of boceprevir plus peginterferon alfa‐2b and ribavirin in patients with chronic hepatitis C genotype 1: a combined analysis of 3 phase 2/3 clini...
  Michael P. Manns, Jonathan McCone, M. Davis, Lorenzo Rossaro, Eugene R. Schiff, Mitchel L. Shiffman, Bruce R. Bacon, Marc Bourlière, Mark S. Sulkowski, Savino Bruno, L...> ;Liver International. 2014 May 1
• 3 citations
  Boceprevir plus peginterferon α-2b/ribavirin in chronic hepatitis C genotype 1: impact of baseline viral load on sustained virologic response.
  S.C. Gordon, K. Rajender Reddy, Ira M. Jacobson, Fred Poordad, Jean-Pierre Bronowicki, Bruce R. Bacon, Maria Buti, Ke-Qin Hu, Lisa D. Pedicone, Margaret Burroughs, Cli...> ;Journal of Clinical Gastroenterology. 2013 Oct 1
• 58 citations
  Cost-Effectiveness of Boceprevir in Patients Previously Treated for Chronic Hepatitis C Genotype 1 Infection in the United States
  Jagpreet Chhatwal, S. Ferrante, Cliff Brass, Antoine C. El Khoury, Margaret Burroughs, Bruce R. Bacon, Rafael Esteban-Mur, Elamin H. Elbasha> ;Value in Health. 2013 Sep 1
• Join now to see all

Other

• Screening for hereditary hemochromatosis 
  Bacon BR, Schrier SL
  http://www.uptodate.com/contents/screening-for-hereditary-hemochromatosis
  UpToDate, Wolters Kluwer Health - 2012-08-21
• Treatment of hereditary hemochromatosis 
  Bacon BR, Schrier SL
  http://www.uptodate.com/contents/treatment-of-hereditary-hemochromatosis
  UpToDate, Wolters Kluwer Health - 2012-05-29
• Genetics of hereditary hemochromatosis 
  Bacon BR, Schrier SL
  http://www.uptodate.com/contents/genetics-of-hereditary-hemochromatosis
  UpToDate, Wolters Kluwer Health - 2012-12-05
• Hepatic iron concentration and hepatic iron index in the diagnosis of iron overload and hereditary hemochromatosis 
  Bacon BR
  http://www.uptodate.com/contents/hepatic-iron-concentration-and-hepatic-iron-index-in-the-diagnosis-
  UpToDate, Wolters Kluwer Health - 2012-09-06
• Iron overload syndromes other than hereditary hemochromatosis 
  Bacon BR, Schrier SL
  http://www.uptodate.com/contents/iron-overload-syndromes-other-than-hereditary-hemochromatosis
  UpToDate, Wolters Kluwer Health - 2012-08-01
• Clinical manifestations of hereditary hemochromatosis 
  Bacon BR, Schrier SL
  http://www.uptodate.com/contents/clinical-manifestations-of-hereditary-hemochromatosis
  UpToDate, Wolters Kluwer Health - 2012-08-21
• Pathophysiology and diagnosis of iron overload syndromes 
  Bacon BR, Schrier SL
  http://www.uptodate.com/contents/pathophysiology-and-diagnosis-of-iron-overload-syndromes
  UpToDate, Wolters Kluwer Health - 2012-12-05
• Chelation therapy for iron overload states 
  Bacon BR, Schrier SL
  http://www.uptodate.com/contents/chelation-therapy-for-iron-overload-states
  UpToDate, Wolters Kluwer Health - 2013-03-27
• Join now to see all